Raymond James Financial Services Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,318
| Closed | -$3.97M | – | 3425 |
|
|
2021
Q1 | $3.97M | Sell |
18,318
-15,835
| -46% | -$2.98M | 0.01% | 1006 |
|
|
2020
Q4 | $3.94M | Buy |
34,153
+6,701
| +24% | +$751K | 0.01% | 939 |
|
|
2020
Q3 | $2.67M | Buy |
27,452
+10,991
| +67% | +$1.26M | 0.01% | 1031 |
|
|
2020
Q2 | $2.02M | Sell |
16,461
-508
| -3% | -$57.6K | 0.01% | 1117 |
|
|
2020
Q1 | $1.49M | Buy |
16,969
+546
| +3% | +$57.8K | 0.01% | 1032 |
|
|
2019
Q4 | $1.72M | Sell |
16,423
-853
| -5% | -$95.6K | 0.01% | 1238 |
|
|
2019
Q3 | $1.99M | Sell |
17,276
-1,674
| -9% | -$254K | 0.01% | 1114 |
|
|
2019
Q2 | $3.27M | Buy |
18,950
+1,686
| +10% | +$292K | 0.01% | 852 |
|
|
2019
Q1 | $2.91M | Buy |
17,264
+734
| +4% | +$109K | 0.01% | 886 |
|
|
2018
Q4 | $1.61M | Sell |
16,530
-1,184
| -7% | -$155K | 0.01% | 1015 |
|
|
2018
Q3 | $3.06M | Buy |
17,714
+8,437
| +91% | +$1.22M | 0.01% | 851 |
|
|
2018
Q2 | $1.29M | Buy |
9,277
+3,990
| +75% | +$567K | 0.01% | 1267 |
|
|
2018
Q1 | $596K | Buy |
5,287
+916
| +21% | +$115K | ﹤0.01% | 1618 |
|
|
2017
Q4 | $577K | Buy |
4,371
+671
| +18% | +$78.8K | ﹤0.01% | 1630 |
|
|
2017
Q3 | $376K | Buy |
3,700
+581
| +19% | +$62.2K | ﹤0.01% | 1894 |
|
|
2017
Q2 | $313K | Buy |
3,119
+855
| +38% | +$92K | ﹤0.01% | 1964 |
|
|
2017
Q1 | $274K | Buy |
+2,264
| New | +$278K | ﹤0.01% | 1954 |
|
|
2016
Q4 | – | Sell |
-18,525
| Closed | -$2.46M | – | 2466 |
|
|
2016
Q3 | $2.46M | Buy |
+18,525
| New | +$1.77M | 0.02% | 671 |
|
Other funds holding GWPH
Raymond James Financial Services Advisors's GWPH Position: Q2 2021 in Review
Raymond James Financial Services Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 18,318 shares — an estimated $3.97M sold.
Raymond James Financial Services Advisors first reported a position in GWPH in Q3 2016 and held it in 18 quarters. The position peaked at $3.97M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Raymond James Financial Services Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 18,318 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.97M.
- Raymond James Financial Services Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 18 quarters.
- Raymond James Financial Services Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.97M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Raymond James Financial Services Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.